Our observations demonstrate that activation of PPARβ/δ by a specific agonist reduces the TNFα-induced mRNA levels of genes known to be involved in the regulation of human pancreatic cancer cell invasion and metastasis, and this negative regulation is also manifested at the protein level. Here, TNF is linked to pancreatic neoplasm.